Patients with Hereditary Hemorrhagic Telangectasia (HHT) Exhibit a Deficit of Polymorphonuclear Cell and Monocyte Oxidative Burst and Phagocytosis: A Possible Correlation with Altered Adaptive Immune Responsiveness in HHT

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|10|1209-1215

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.10, 2006-04, pp. : 1209-1215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HHT in Childhood: Screening for Special Patients

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1221-1225

Bentham Science Publishers

Access to resources Recommend Favorite

Hereditary Haemorrhagic Telangiectasia (HHT): Genetic and Molecular Aspects

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1173-1193

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Recurrent Epistaxis in HHT

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1237-1242

Bentham Science Publishers

Access to resources Recommend Favorite

The Need for an Interdisciplinary Network of Investigations on HHT

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1249-1251

Bentham Science Publishers

Access to resources Recommend Favorite

Ablation of T-Helper 1 Cell Derived Cytokines and of Monocyte-Derived Tumor Necrosis Factor- in Hereditary Hemorrhagic Telangiectasia: Immunological Consequences and Clinical Considerations

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1201-1208

Bentham Science Publishers

Access to resources Recommend Favorite